Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:54 AM
Ignite Modification Date: 2025-12-26 @ 2:44 AM
NCT ID: NCT03747302
Description: Adverse events not collected
Frequency Threshold: 0
Time Frame: Adverse events not anticipated over the < 1 hour of the study for a participant which only collects survey data about views of HPV vaccine
Study: NCT03747302
Study Brief: HPV Message Testing and Social Media Campaign
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
HPV Messaging Subjects are randomized to receive one of five messages on one of the four themes about HPV vaccination. Social Media Message about HPV and HPV vaccine: Messages educate parents with facts about HPV vaccination. 0 None 0 0 0 0 View
Control Message Subjects are randomized to receive one of five messages about electronic cigarettes. Social media message about risk of electronic cigarettes.: Messages educate parents with facts about electronic cigarettes. This is an attention control group without outcomes obtained. 0 None 0 0 0 0 View
Serious Events(If Any):
Other Events(If Any):